1116 related articles for article (PubMed ID: 33038595)
1. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
[TBL] [Abstract][Full Text] [Related]
2. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
[TBL] [Abstract][Full Text] [Related]
3. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
[TBL] [Abstract][Full Text] [Related]
4. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.
Dafsari HS; Petry-Schmelzer JN; Ray-Chaudhuri K; Ashkan K; Weis L; Dembek TA; Samuel M; Rizos A; Silverdale M; Barbe MT; Fink GR; Evans J; Martinez-Martin P; Antonini A; Visser-Vandewalle V; Timmermann L; ;
Brain Stimul; 2018; 11(4):904-912. PubMed ID: 29655586
[TBL] [Abstract][Full Text] [Related]
5. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
9. Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.
Dafsari HS; Reker P; Stalinski L; Silverdale M; Rizos A; Ashkan K; Barbe MT; Fink GR; Evans J; Steffen J; Samuel M; Dembek TA; Visser-Vandewalle V; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Timmermann L;
Mov Disord; 2018 Jan; 33(1):99-107. PubMed ID: 29150860
[TBL] [Abstract][Full Text] [Related]
10. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
Tan ZG; Zhou Q; Huang T; Jiang Y
Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
[TBL] [Abstract][Full Text] [Related]
11. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
[TBL] [Abstract][Full Text] [Related]
12. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.
Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L;
J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689
[TBL] [Abstract][Full Text] [Related]
14. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
[TBL] [Abstract][Full Text] [Related]
16. King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease.
DiMarzio M; Pilitsis JG; Gee L; Peng S; Prusik J; Durphy J; Ramirez-Zamora A; Hanspal E; Molho E; McCallum SE
Neuromodulation; 2018 Aug; 21(6):617-622. PubMed ID: 29608802
[TBL] [Abstract][Full Text] [Related]
17. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
Odekerken VJ; Boel JA; Schmand BA; de Haan RJ; Figee M; van den Munckhof P; Schuurman PR; de Bie RM;
Neurology; 2016 Feb; 86(8):755-61. PubMed ID: 26819458
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
[TBL] [Abstract][Full Text] [Related]
19. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.
Zahodne LB; Okun MS; Foote KD; Fernandez HH; Rodriguez RL; Wu SS; Kirsch-Darrow L; Jacobson CE; Rosado C; Bowers D
J Neurol; 2009 Aug; 256(8):1321-9. PubMed ID: 19363633
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
